RSS Feeds
Intravenous Esomeprazole for Prevention of Recurrent Peptic Ulcer Bleeding
- Joseph J.Y. Sung, MD;
- Alan Barkun, MD;
- Ernst J. Kuipers, MD;
- Joachim Mössner, MD;
- Dennis M. Jensen, MD;
- Robert Stuart, MD;
- James Y. Lau, MD;
- Henrik Ahlbom, BSc;
- Jan Kilhamn, MD;
- Tore Lind, MD; and
- for the Peptic Ulcer Bleed Study Group*
- From the Institute of Digestive Diseases, Chinese University of Hong Kong, Hong Kong, China; McGill University Health Center, Montreal, Quebec, Canada; Erasmus MC University Medical Center, Rotterdam, the Netherlands; Medizinische Klinik und Poliklinik II, University of Leipzig, Leipzig, Germany; David Geffen School of Medicine at the University of California, Los Angeles, and Center for Ulcer Research and Education (CURE), Digestive Diseases Research Center, Los Angeles, California; Glasgow Royal Infirmary, Glasgow, United Kingdom; and AstraZeneca Research and Development, Mölndal, Sweden.
-
Figure 1. Study flow diagram.GI = gastrointestinal; ITT = intention-to-treat; PP = per-protocol.
-
Figure 2. Kaplan–Meier estimate of the cumulative percentage of patients with recurrent bleeding within 30 days.
Related Clinical Content
